Indegene Q2 FY27 Revenue Surges 39.5% YoY to ₹11,223 Crore, EBITDA Up 32%
Indegene Limited reported Q2 FY27 revenue of ₹11,223 crore, a 39.5% YoY increase. EBITDA grew 32.0% YoY to ₹1,873 crore, with margins at 16.7%. PAT was ₹1,123 crore, up 10.0% YoY. Active clients increased 40.8% to 107, and $1M+ clients rose to 59. Management expects continued growth and margin expansion.
The announcement details significant financial performance improvements and positive growth indicators, which are material for investors and stakeholders. The strong YoY growth and positive future outlook are likely to have a considerable impact on the company's valuation and market perception.
The company reported strong YoY growth in revenue and EBITDA, alongside an expanding client base and improved operational metrics. Management commentary indicates positive future outlook with expected growth and margin expansion.
Indegene Limited announced its financial results for the second quarter and half-year ended September 30, 2026. The company reported a significant year-over-year (YoY) growth in revenue from operations, which increased by 39.5% to ₹11,223 million (₹112.23 crore). In USD terms, revenue grew by 27.5% YoY to $117.5 million.
EBITDA for the quarter rose by 32.0% YoY to ₹1,873 million (₹18.73 crore), with the EBITDA margin standing at 16.7%. Profit after tax (PAT) increased by 10.0% YoY to ₹1,123 million (₹11.23 crore), although the profit margin saw a slight decrease to 10.0% from 12.7% in the prior year period.
The company highlighted strong growth drivers including deeper penetration of top accounts and an expanding client base. The number of active clients grew by 40.8% YoY to 107. Clients with $1 million+ revenue increased to 59, up from 40 in Q2 FY26. Revenue per employee (RPE) also saw a healthy increase of 15.5% YoY to $79.6K.
Management commentary indicated that despite an annual wage increase, EBITDA margins remained stable. They anticipate faster EBITDA and PAT growth in upcoming quarters due to improved yields on investments and lower amortization. The company also noted significant deal wins in GenAI-enabled transformation and upstream engagements, with a healthy pipeline expected to drive growth and margin expansion in the second half of FY27.
Key business highlights include a 40.8% YoY increase in active client relationships to 107 and a 47.5% YoY increase in clients with $1 million+ revenue to 59. Global delivery capacity expanded with total employees reaching 5,952 and delivery employees at 5,090, a 13.5% and 12.5% YoY increase respectively. Voluntary attrition improved by 80 bps YoY to 15.4%.
What to do with a filing like this
Indegene Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indegene Limited. Read the original for the full detail.